30Oct
[Video] I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues - Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products
AGG is pleased to present the second episode in a podcast series titled, “I Wish I Know What I Know Now: Conversations with AGG on FDA Issues,” covering key due diligence issues to consider when acquiring or investing in life science companies or products. In this episode, AGG partner Alan G. Minsk and Brian A. Teras provides an overview of the diligence process, potential red flags, common mistakes, and other factors to consider during the due diligence process. Each month, we'll release a...
By:
Arnall Golden Gregory LLP
Related
On June 17, 2019, Canada’s finance minister tabled a Notice of Ways and Means Motion regarding the ...
Read More >
Department Clarifies that Law Will Not Apply to Properly Classified Independent Contractors - On Se...
Read More >
With the issuance of a revised order by the Massachusetts Supreme Judicial Court (“SJC”) dated May...
Read More >
It is without question that changes to present-day life caused by the spread of COVID-19 are both ma...
Read More >
The IRS issued final regulations on June 20, 2019 (the “Final Regulations”), which will allow empl...
Read More >
As employers seek to reduce costs and time in the hiring process through artificial intelligence (AI...
Read More >